PharMerica

PharMerica is a United States pharmacy-services company focused primarily on institutional and post-acute care rather than conventional walk-in retail pharmacy. Its principal customers include nursing facilities, senior-living communities, hospice organizations, public-health organizations, and other post-acute-care providers. The company supports these organizations through medication dispensing, delivery, packaging, pharmacy management, clinical support, and related medication-use services. The business was formed in January 2007 through the combination of Kindred Healthcare's pharmacy operation with a subsidiary of AmerisourceBergen. That formation brought together pharmacy assets serving institutional-care settings and established PharMerica as a sizable participant in the institutional pharmacy market. Its operating model is designed around the recurring and operationally complex needs of facilities caring for older adults, medically fragile patients, hospice patients, and people requiring extended medication regimens. Instead of relying mainly on individual consumer prescriptions, PharMerica works through facility and care-provider relationships, where medication accuracy, delivery schedules, packaging, formulary management, regulatory compliance, and coordination with nurses and prescribers are central to the service proposition. The company has operated a network serving customers across the United States. Its Louisville, Kentucky headquarters has been associated with corporate operations, while Tampa, Florida has been identified as a major customer-support location. Reported business units and affiliated operations have included ValueMed, the long-term-care pharmacy business, Amerita for specialty and home infusion, Onco360 for oncology pharmacy, and OnePoint Patient Care for hospice pharmacy. The broader portfolio therefore extends beyond traditional institutional dispensing into specialty medicines, infusion therapy, oncology, and hospice-focused pharmacy support. PharMerica has also been involved in significant consolidation within the institutional pharmacy sector. In 2011, Omnicare proposed acquiring the company in a transaction valued at $457 million for PharMerica's outstanding shares. The Federal Trade Commission challenged the proposed acquisition, arguing that it could reduce competition and lead to higher drug prices. Omnicare allowed its offer to expire in February 2012 after the regulatory dispute. In 2017, reports stated that KKR would acquire PharMerica in a transaction valued at approximately $1.4 billion including debt. PharMerica subsequently became associated with the BrightSpring Health Services platform, which combines pharmacy, home health, hospice, and other services for complex-care populations. The company remains positioned as a specialized healthcare-services brand whose value lies in integrating pharmacy operations with institutional care delivery. Its customers generally need dependable medication supply, clinical oversight, technology-enabled ordering and documentation, and services adapted to facility-based, home-based, hospice, and specialty-care environments. A 2023 cybersecurity incident involving PharMerica and its parent company brought privacy and data-security risks associated with large healthcare-service organizations into public view. The incident was reported to have affected approximately six million individuals and involved personal information including names, dates of birth, and Social Security numbers.

PharMerica was established in January 2007 through the merger of Kindred Healthcare's pharmacy business with a subsidiary of AmerisourceBergen. The combination created a company dedicated to institutional pharmacy services, particularly medication supply and management for long-term-care facilities and other organized-care settings. Its business model differed from retail pharmacy because the principal customers were care organizations rather than individual walk-in patients. From its early development, PharMerica served nursing facilities, senior-living communities, public-health organizations, and post-acute providers. The company built its role around recurring institutional medication needs: prescription fulfillment, scheduled delivery, packaging, pharmacy consultation, medication administration support, and coordination with facility staff and prescribers. Its geographic reach expanded across the United States, and Louisville, Kentucky became its headquarters. A major customer-support center was also associated with Tampa, Florida. PharMerica became an important participant in consolidation in the institutional pharmacy market. In August 2011, Omnicare offered to acquire the company for approximately $457 million in equity value. The Federal Trade Commission sued to block the transaction, arguing that the proposed combination could lessen competition and produce higher drug prices. The offer ultimately expired in February 2012, leaving PharMerica independent from that proposed transaction. The company later broadened the range of pharmacy and care settings it served. Reported operations and affiliates included Pharmacy Alternatives, PropacPayless, ChemRX, and CIPRx. Its named business units included ValueMed, the long-term-care operation, Amerita for specialty and home infusion, Onco360 for oncology pharmacy, and OnePoint Patient Care for hospice pharmacy. These activities gave the brand exposure to specialty medicines, infusion treatment, cancer care, hospice, and other complex-care environments in addition to standard institutional dispensing. In August 2017, CNBC reported that KKR would acquire PharMerica in a deal valued at about $1.4 billion including debt. PharMerica subsequently became part of the BrightSpring Health Services platform. Through that ownership structure, the brand was aligned with a broader healthcare-services organization spanning pharmacy and other services for people with complex medical and support needs. In March 2023, PharMerica and BrightSpring disclosed a cybersecurity incident. The companies said they had learned of suspicious network activity and began an internal investigation with outside cybersecurity specialists. Public reporting indicated that the breach affected approximately six million individuals and involved sensitive personal data, including names, dates of birth, and Social Security numbers. The incident highlighted the privacy and security obligations facing pharmacy providers that maintain large patient and customer-information systems. PharMerica's current identity is therefore best understood as that of a specialized healthcare-services brand, not a consumer retail pharmacy chain. Its core proposition is the integration of pharmacy operations with long-term care, hospice, specialty, oncology, home infusion, and post-acute treatment settings. The company operates in a field where dependable supply, medication accuracy, clinical coordination, regulatory compliance, and service continuity are central purchasing considerations.

1. 2023Healthcare data-security incident disclosed

   PharMerica and BrightSpring report a network incident that reportedly affected approximately six million people.

   Source
2. 2017KKR acquisition reported

   KKR is reported to be acquiring PharMerica in a transaction including assumed debt.

   Source
3. 2012Omnicare offer expires

   The proposed Omnicare transaction ends after the offer is allowed to expire amid the FTC challenge.

   Source
4. 2011Omnicare announces acquisition proposal

   Omnicare makes a bid for PharMerica, prompting an antitrust challenge from the Federal Trade Commission.

   Source
5. 2007PharMerica is formed

   Kindred Healthcare's pharmacy business and an AmerisourceBergen subsidiary are combined to create PharMerica.

   Source

A specialized institutional and post-acute pharmacy partner for organizations caring for seniors, medically complex patients, hospice patients, and other populations requiring coordinated medication services.

• Long-Term CareInstitutional pharmacy

  PharMerica's core long-term-care offering supports nursing facilities, senior-living communities, and other institutional providers. Services may include prescription dispensing, medication packaging, scheduled delivery, pharmacy consultation, clinical review, and coordination with facility personnel. The model is designed for patients whose medicines are administered in organized-care environments and whose treatment plans require recurring oversight and dependable logistics.

• AmeritaSpecialty and home infusion pharmacy

  Amerita is identified as PharMerica's specialty and home infusion business. It supports patients who require infusion therapies or other complex specialty-pharmacy services outside a conventional retail setting. Such services generally involve medication sourcing, clinical coordination, patient or caregiver support, and delivery arrangements adapted to home-based treatment.

• Onco360Oncology pharmacy

  Onco360 is the oncology-focused pharmacy operation associated with PharMerica. Its scope centers on medicines and support for cancer-care patients, an area in which specialty distribution, adherence assistance, financial or access coordination, and communication with oncology teams can be important components of the service model.

• OnePoint Patient CareHospice pharmacy

  OnePoint Patient Care provides pharmacy services oriented toward hospice organizations and patients receiving end-of-life care. The offering is adapted to hospice workflows and emphasizes timely access to medications, coordination with care teams, and support for symptom-management regimens in facility and community settings.

• ValueMedPharmacy services

  ValueMed is listed among PharMerica's operating departments. Public reference material identifies it as part of the company's pharmacy-services portfolio, although detailed standalone information about its product scope and commercial history is limited.

• 2017PharMerica enters KKR ownershipM&A

  After the unsuccessful Omnicare proposal, PharMerica became the subject of a reported KKR acquisition as healthcare-services businesses continued to consolidate.

  What changed. KKR reportedly acquired PharMerica in a transaction valued at approximately $1.4 billion including debt, after which the company became associated with the BrightSpring platform.

  Aftermath. PharMerica continued operating as a specialized pharmacy-services business within a broader privately owned healthcare-services group.

  Reported transaction value including debt. $1.4 billion (2017)

  Source

• 2023PharMerica healthcare data breachControversy

  PharMerica and BrightSpring Health Services disclosed suspicious activity on their computer network in March 2023. The investigation identified a breach reportedly affecting approximately six million individuals and potentially exposing names, dates of birth, and Social Security numbers.

  Source

• 2017KKR reported to be acquiring PharMerica

  Reports stated that KKR would acquire PharMerica in a transaction valued at approximately $1.4 billion including debt. The transaction placed PharMerica within a broader privately owned healthcare-services structure.

  M&A
  Source
• 2012Omnicare offer expires after FTC challenge

  Omnicare permitted its offer for PharMerica shareholders to expire after the FTC's effort to block the proposed combination.

  M&ARegulation
  Source
• 2011Omnicare makes offer for PharMerica

  Omnicare proposed acquiring PharMerica in a transaction reported at $457 million for the company's outstanding shares. The Federal Trade Commission challenged the proposal on competition grounds, expressing concern that the deal could contribute to higher drug prices.

  M&ARegulation
  Source

1. PharMerica
2. PharMerica Notice of Data Breach
3. PharMerica official website